🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

RecruitingNAAges 18 Years - anyAllNavamindradhiraj University
NCT06989892 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml) Exclusion Criteria: * Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours. * Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.
💊

What it tests

  • Super High-flux dialyzer (Elisio 19HDx)
  • High-flux dialyzer (Elisio 19H)
📍

Where

1 site
Navamindhradhiraj university
Dusit, Thailand
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy